Snowden Capital Advisors LLC Becton Dickinson & CO Transaction History

Snowden Capital Advisors LLC

  • $3.29 Billion
  • Q3 2024

A detailed history of Snowden Capital Advisors LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 3,324 shares of BDX stock, worth $758,270. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,324
Previous 3,668 9.38%
Holding current value
$758,270
Previous $857,000 6.53%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$221.47 - $242.41 $76,185 - $83,389
-344 Reduced 9.38%
3,324 $801,000
Q2 2024

Aug 14, 2024
SELL
$225.07 - $246.17 $618,717 - $676,721
-2,749 Reduced 42.84%
3,668 $857,000
Q1 2024

May 15, 2024
BUY
$233.45 - $247.73 $339,669 - $360,447
1,455 Added 29.32%
6,417 $1.59 Million
Q4 2023

Feb 14, 2024
SELL
$232.24 - $267.23 $190,436 - $219,128
-820 Reduced 14.18%
4,962 $1.21 Million
Q3 2023

Nov 14, 2023
SELL
$254.9 - $283.59 $150,900 - $167,885
-592 Reduced 9.29%
5,782 $1.49 Million
Q2 2023

Aug 14, 2023
BUY
$238.39 - $265.32 $6,436 - $7,163
27 Added 0.43%
6,374 $1.68 Million
Q1 2023

May 15, 2023
BUY
$229.71 - $259.35 $918 - $1,037
4 Added 0.06%
6,347 $1.57 Million
Q4 2022

Feb 13, 2023
BUY
$218.29 - $256.91 $101,723 - $119,720
466 Added 7.93%
6,343 $1.61 Million
Q3 2022

Nov 09, 2022
SELL
$51.03 - $264.23 $5,154 - $26,687
-101 Reduced 1.69%
5,877 $1.31 Million
Q2 2022

Aug 12, 2022
SELL
$234.74 - $275.42 $65,257 - $76,566
-278 Reduced 4.44%
5,978 $1.47 Million
Q1 2022

May 16, 2022
BUY
$243.64 - $270.48 $1.3 Million - $1.44 Million
5,327 Added 573.41%
6,256 $1.66 Million
Q4 2021

Feb 14, 2022
BUY
$230.08 - $250.94 $213,744 - $233,123
929 New
929 $233,000
Q3 2021

Feb 05, 2024
BUY
$232.72 - $256.47 $616,242 - $679,132
2,648 Added 45.8%
8,430 $2.07 Billion
Q2 2021

Jan 08, 2024
BUY
$232.65 - $254.58 $999,697 - $1.09 Million
4,297 Added 116.93%
7,972 $1.94 Billion
Q1 2021

Jan 08, 2024
BUY
$232.09 - $256.88 $558,872 - $618,567
2,408 Added 190.06%
3,675 $894 Million
Q4 2020

Jan 08, 2024
BUY
$221.92 - $245.94 $29,293 - $32,464
132 Added 11.63%
1,267 $317 Million
Q3 2020

Jan 08, 2024
BUY
$215.77 - $276.76 $7,120 - $9,133
33 Added 2.99%
1,135 $264 Million
Q2 2020

Jan 08, 2024
SELL
$219.9 - $263.41 $323,033 - $386,949
-1,469 Reduced 57.14%
1,102 $264 Million
Q1 2020

Jan 08, 2024
SELL
$195.69 - $279.01 $34,050 - $48,547
-174 Reduced 6.34%
2,571 $591 Million
Q4 2019

Jan 30, 2024
BUY
$236.45 - $266.82 $327,956 - $370,079
1,387 Added 102.14%
2,745 $747 Million
Q4 2019

Jan 08, 2024
BUY
$236.45 - $266.82 $327,956 - $370,079
1,387 Added 102.14%
2,745 $747 Million
Q3 2019

Jan 30, 2024
SELL
$230.58 - $256.08 $24,902 - $27,656
-108 Reduced 7.37%
1,358 $344 Million
Q3 2019

Jan 08, 2024
SELL
$230.58 - $256.08 $3.49 Million - $3.87 Million
-15,126 Reduced 91.76%
1,358 $344 Million
Q2 2019

Jan 30, 2024
SELL
$217.4 - $246.08 $938,298 - $1.06 Million
-4,316 Reduced 74.65%
1,466 $370 Million
Q2 2019

Jan 08, 2024
BUY
$217.4 - $246.08 $3.28 Million - $3.71 Million
15,093 Added 1085.05%
16,484 $370 Million
Q1 2019

Jan 08, 2024
BUY
$206.05 - $248.17 $43,064 - $51,867
209 Added 17.68%
1,391 $347 Million
Q4 2018

Jan 08, 2024
SELL
$204.73 - $257.93 $1.1 Million - $1.39 Million
-5,395 Reduced 82.03%
1,182 $266 Million
Q3 2018

Jan 08, 2024
BUY
$233.07 - $256.0 $146,367 - $160,768
628 Added 10.56%
6,577 $1.72 Billion
Q2 2018

Jan 08, 2024
BUY
$208.1 - $233.85 $35,377 - $39,754
170 Added 2.94%
5,949 $1.43 Billion
Q1 2018

Jan 08, 2024
SELL
$205.46 - $240.27 $616 - $720
-3 Reduced 0.05%
5,779 $1.25 Billion

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email